Gene Expression Profiles and Metformin Efficacy in Type 2 Diabetes
Status:
Unknown status
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
Our general aim is to investigate whether messenger RNA (mRNA) and/or microRNA (miRNA)
expression profiles in white blood cells, predict metformin monotherapy efficacy in patients
with type 2 diabetes.